Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.55 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.55 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.55 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.55 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.55 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.55 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.55 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.55 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.55 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8488876 | 0.98 | HTT (0.59) | ALDH1A1MAPK1L3MBTL1HTTMAPT | |
| SCHEMBL905777 | 0.98 | HTT (0.59) | ALDH1A1MAPK1L3MBTL1HTTMAPT | |
| SCHEMBL2932079 | 0.98 | HTT (0.59) | ALDH1A1MAPK1L3MBTL1HTTMAPT | |
| SCHEMBL3335775 | 0.98 | HTT (0.59) | ALDH1A1MAPK1L3MBTL1HTTMAPT | |
| SCHEMBL8491249 | 0.98 | HTT (0.59) | ALDH1A1MAPK1L3MBTL1HTTMAPT | |
| SCHEMBL8854045 | 0.98 | HTT (0.59) | ALDH1A1MAPK1L3MBTL1HTTMAPT | |
| SCHEMBL17004058 | 0.98 | HTT (0.59) | ALDH1A1MAPK1L3MBTL1HTTMAPT | |
| SCHEMBL16197784 | 0.98 | HTT (0.59) | ALDH1A1MAPK1L3MBTL1HTTMAPT | |
| SCHEMBL9814068 | 0.98 | HTT (0.59) | ALDH1A1MAPK1L3MBTL1HTTMAPT | |
| Sebacic Acid SCHEMBL28606878 | 0.98 | HTT (0.59) | ALDH1A1MAPK1L3MBTL1HTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 380 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240210727-A1 | OPHTHALMIC ARTICLES MADE FROM CELLULOSE ESTER COMPOSITIONS HAVING HIGH TOUGHNESS AND DIMENSIONAL STABILITY | EASTMAN CHEMICAL COMPANY (US) | 2024-06-27 | — | — | US | claimed |
| EP-4320187-A1 | OPHTHALMIC ARTICLES MADE FROM CELLULOSE ESTER COMPOSITIONS HAVING HIGH TOUGHNESS AND DIMENSIONAL STABILITY | Eastman Chemical Company (US) | 2024-02-14 | — | — | EP | claimed |
| CN-117178017-A | Ophthalmic articles having high toughness and dimensional stability made from cellulose ester compositions | 伊士曼化工公司 | 2023-12-05 | — | — | CN | claimed |
| WO-2022216473-A1 | OPHTHALMIC ARTICLES MADE FROM CELLULOSE ESTER COMPOSITIONS HAVING HIGH TOUGHNESS AND DIMENSIONAL STABILITY | EASTMAN CHEMICAL COMPANY (US) | 2022-10-13 | — | — | WO | claimed |
| CN-110662746-B | Compounds as orally administered prodrugs of beta-lactamase inhibitors, pharmaceutical compositions thereof and use for treating bacterial infections | 阿里萨制药有限公司 | 2022-08-19 | — | — | CN | claimed |
| EP-0287416-B1 | Process for the manufacture of masticated polyvinyl butyral for the bonding of a supporting bed to a screen, and products obtained | SAINT GOBAIN VITRAGE (FR) | 1994-07-27 | — | — | EP | claimed |
| US-5187217-A | Reacting butyral with a Polyvinyl Alcohol having 98% hydrolysis and a viscosity of at least 50 cP to obtain hydroxylation of 23 to 25% using an acid catalyst, plasticizer and emulsifier | SAINT-GOBAIN VITRAGE (FR) | 1993-02-16 | — | — | US | claimed |
| EP-4368686-B1 | LUBRICITY IMPROVER COMPOSITION FOR FUEL OIL AND USE THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2026-05-27 | — | — | EP | disclosed |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | ARYLESSENCE INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260021190-A1 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES COMPRISING A PENTA-VALENT SUGAR CLUSTER FOR TREATMENT OF DIABETES | MERCK SHARP & DOHME LLC (US) | 2026-01-22 | — | — | US | disclosed |
| US-12521455-B2 | Kisspeptin receptor (KISS1R) targeted therapeutics and uses thereof | RADIONETICS ONCOLOGY, INC. (US) | 2026-01-13 | — | — | US | disclosed |
| US-12522671-B2 | Paramylon-based resin, molding material, molded body, and method for producing paramylon-based resin | NEC CORPORATION (JP) | 2026-01-13 | — | — | US | disclosed |
| WO-2025217074-A1 | KISSPEPTIN RECEPTOR (KISS1R) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY, INC. (US) | 2025-10-16 | — | — | WO | disclosed |
| EP-0121383-B1 | BIS-ESTERS OF DICARBOXYLIC ACIDS WITH AMOXICILLIN AND CERTAIN HYDROXYMETHYLPENICILLANATE 1,1-DIOXIDES | PFIZER INC. (US) | 1986-05-07 | — | — | EP | disclosed |
| EP-0083484-B1 | 1,1-ALKANEDIOL DICARBOXYLATE LINKED ANTIBACTERIAL AGENTS | PFIZER INC. (US) | 1986-02-19 | — | — | EP | disclosed |
| EP-0121383-A1 | Bis-esters of dicarboxylic acids with amoxicillin and certain hydroxymethylpenicillanate 1,1-dioxides | PFIZER INC. (US) | 1984-10-10 | — | — | EP | disclosed |
| US-4462934-A | BACTERICIDES FROM PENICILLINS AND PENICILLINASE INHIBITORS | PFIZER INC. (US) | 1984-07-31 | — | — | US | disclosed |
| US-4457924-A | PENICILLINS, OXAPENICILLINS, BETA-LACTAMASE INHIBITORS | PFIZER, INC. (US) | 1984-07-03 | — | — | US | disclosed |
| US-4410461-A | Production of benzylic esters | ASHLAND OIL, INC. (US) | 1983-10-18 | — | — | US | disclosed |
| EP-0083484-A1 | 1,1-Alkanediol dicarboxylate linked antibacterial agents | PFIZER INC. (US) | 1983-07-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260021190-A1 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES COMPRISING A PENTA-VALENT SUGAR CLUSTER FOR TREATMENT OF DIABETES | INSR, GPR119, GLP1R | ALDH1A1 2398/4885MAPK1 3293/4885L3MBTL1 2640/4885 |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | FFAR1, FFAR2, FFAR3 | ALDH1A1 697/4885MAPK1 3240/4885L3MBTL1 4774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.